Brief: Moberg Pharma divests its OTC-business

Moberg Pharma AB (publ)

12/02/2019 24:32

Feb 11 (Reuters) - Moberg Pharma AB (publ)  MBPH.ST :
    * IN ADDITION, A HOLDING CO OWNED BY ROUNDTABLE HEALTHCARE
AND
SIGNET HEALTHCARE HAS UNDERTAKEN TO PROVIDE FINANCING TO THE CO
WITH A TOTAL AMOUNT $5 MILLION
    * MOBERG PHARMA DIVESTS ITS OTC-BUSINESS FOR USD 155 MILLION
AND
SECURES NEW FUNDING FOR MOB-015 IN TRANSFORMATIONAL TRANSACTION
    * MOBERG PHARMA-INTENDS TO USE CASH CONSIDERATION TO REDEEM
ITS
OUTSTANDING BONDS AND TO DISTRIBUTE APPROXIMATELY SEK
43-45/SHARE TO ITS SHAREHOLDERS
    * MOBERG-PARTIES HAVE AGREED ON TERMINATION FEE
,REIMBURSEMENT OF
EXPENSES ON MUTUAL BASIS, ENTAILING THAT CO ENTITLED TO A
TERMINATION FEE OF USD 6 MILLION
    * MOBERG PHARMA -FOLLOWING TRANSACTION, MOBERG PHARMA'S
OPERATIONS
WILL CHANGE FROM SELLING PRODUCTS TO FOCUSING ON MOB-015
    * COMBINED VALUE TO SHAREHOLDERS OF TRANSACTION EQUALS
APPROXIMATELY SEK 78-80 PER SHARE

Source text for Eikon: [ID: nWkr9VJJxv]
Further company coverage:  MBPH.ST 

 ((Reuters.Briefs@thomsonreuters.com;))